Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Oct;70(1):47–52.

High prevalence of antibodies to histones among patients with primary biliary cirrhosis.

E Penner 1, S Muller 1, D Zimmermann 1, M H Van Regenmortel 1
PMCID: PMC1542228  PMID: 3500816

Abstract

Histones are small, basic proteins involved in the packing of DNA into the eucaryotic nucleus. Using an immunodot assay and an enzyme-linked immunosorbent assay (ELISA), sera from patients with liver disease were tested for antibodies to the five individual histones H1, H2A, H2B, H3 and H4. Histones extracted from calf thymus and separated into individual fractions by gel exclusion chromatography were either immobilized on nitrocellulose or adsorbed to microtitre plates and the resulting immune complexes examined via a streptavidin-biotin bridge. Of the liver disease sera tested, only specimens obtained from primary biliary cirrhosis patients contained antibodies reactive with histones. The predominant reactivity was to histone H1 and H2B, and amounted to 74% for IgM antibodies, and 60% for IgG antibodies. Our data indicate that antibodies specific for histones might represent a novel serological marker for primary biliary cirrhosis.

Full text

PDF
47

Images in this article

49Fig. 1
on p.49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitkaci A., Monier J. C., Mamelle N. Enzyme-linked immunosorbent assay for anti-histone antibodies and their presence in systemic lupus erythematosus sera. J Immunol Methods. 1981;44(3):311–322. doi: 10.1016/0022-1759(81)90049-1. [DOI] [PubMed] [Google Scholar]
  2. Butler P. J. The folding of chromatin. CRC Crit Rev Biochem. 1983;15(1):57–91. doi: 10.3109/10409238309102801. [DOI] [PubMed] [Google Scholar]
  3. Cush J. J., Goldings E. A. Drug-induced lupus: clinical spectrum and pathogenesis. Am J Med Sci. 1985 Jul;290(1):36–45. doi: 10.1097/00000441-198507000-00007. [DOI] [PubMed] [Google Scholar]
  4. Eisenberg R. A., Klapper D. G., Cohen P. L. The polypeptide structure of the Sm and RNP nuclear antigens. Mol Immunol. 1983 Feb;20(2):187–195. doi: 10.1016/0161-5890(83)90130-x. [DOI] [PubMed] [Google Scholar]
  5. Fritzler M. J., Tan E. M. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest. 1978 Sep;62(3):560–567. doi: 10.1172/JCI109161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gioud M., Kotzin B. L., Rubin R. L., Joslin F. G., Tan E. M. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. J Immunol. 1983 Jul;131(1):269–274. [PubMed] [Google Scholar]
  7. Gohill J., Cary P. D., Couppez M., Fritzler M. J. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol. 1985 Nov;135(5):3116–3121. [PubMed] [Google Scholar]
  8. Grossman L., Barland P. Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients. Arthritis Rheum. 1981 Jul;24(7):927–931. doi: 10.1002/art.1780240710. [DOI] [PubMed] [Google Scholar]
  9. Hardin J. A., Thomas J. O. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7410–7414. doi: 10.1073/pnas.80.24.7410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harmon C. E., Portanova J. P. Drug-induced lupus: clinical and serological studies. Clin Rheum Dis. 1982 Apr;8(1):121–135. [PubMed] [Google Scholar]
  11. Hawkes R., Niday E., Gordon J. A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem. 1982 Jan 1;119(1):142–147. doi: 10.1016/0003-2697(82)90677-7. [DOI] [PubMed] [Google Scholar]
  12. Isenberg I. Histones. Annu Rev Biochem. 1979;48:159–191. doi: 10.1146/annurev.bi.48.070179.001111. [DOI] [PubMed] [Google Scholar]
  13. Johns E. W. Studies on histones. 7. Preparative methods for histone fractions from calf thymus. Biochem J. 1964 Jul;92(1):55–59. doi: 10.1042/bj0920055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kendall C., Ionescu-Matiu I., Dreesman G. R. Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1983 Feb 11;56(3):329–339. doi: 10.1016/s0022-1759(83)80022-2. [DOI] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Laskov R., Muller S., Hochberg M., Giloh H., Van Regenmortel M. H., Eilat D. Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice. Eur J Immunol. 1984 Jan;14(1):74–81. doi: 10.1002/eji.1830140114. [DOI] [PubMed] [Google Scholar]
  17. Lindenborn-Fotinos J., Baum H., Berg P. A. Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology. 1985 Sep-Oct;5(5):763–769. doi: 10.1002/hep.1840050510. [DOI] [PubMed] [Google Scholar]
  18. McGhee J. D., Felsenfeld G. Nucleosome structure. Annu Rev Biochem. 1980;49:1115–1156. doi: 10.1146/annurev.bi.49.070180.005343. [DOI] [PubMed] [Google Scholar]
  19. Muller S., Jockers-Wretou E., Sekeris C. E., Van Regenmortel M. H., Bautz F. A. Characterization of a monoclonal antibody reacting with histone H3. FEBS Lett. 1985 Mar 25;182(2):459–464. doi: 10.1016/0014-5793(85)80354-9. [DOI] [PubMed] [Google Scholar]
  20. Muller S., Mazen A., Martinage A., Van Regenmortel M. H. Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits. EMBO J. 1984 Oct;3(10):2431–2436. doi: 10.1002/j.1460-2075.1984.tb02150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Muller S., Plaue S., Couppez M., Van Regenmortel M. H. Comparison of different methods for localizing antigenic regions in histone H2A. Mol Immunol. 1986 Jun;23(6):593–601. doi: 10.1016/0161-5890(86)90095-7. [DOI] [PubMed] [Google Scholar]
  22. Penner E., Kindas-Mügge I., Hitchman E., Sauermann G. Nuclear antigens recognized by antibodies present in liver disease sera. Clin Exp Immunol. 1986 Feb;63(2):428–433. [PMC free article] [PubMed] [Google Scholar]
  23. Romac J., Bouley J. P., Van Regenmortel M. H. Enzyme-linked immunosorbent assay in the study of histone antigens and nucleosome structure. Anal Biochem. 1981 May 15;113(2):366–371. doi: 10.1016/0003-2697(81)90090-7. [DOI] [PubMed] [Google Scholar]
  24. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  25. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  26. Thomas J. O., Wilson C. M., Hardin J. A. The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin-sensitive regions. FEBS Lett. 1984 Apr 9;169(1):90–96. doi: 10.1016/0014-5793(84)80295-1. [DOI] [PubMed] [Google Scholar]
  27. Towbin H., Gordon J. Immunoblotting and dot immunobinding--current status and outlook. J Immunol Methods. 1984 Sep 4;72(2):313–340. doi: 10.1016/0022-1759(84)90001-2. [DOI] [PubMed] [Google Scholar]
  28. Zrein M., De Marcillac G., Van Regenmortel M. H. Quantitation of rheumatoid factors by enzyme immunoassay using biotinylated human IgG. J Immunol Methods. 1986 Mar 13;87(2):229–237. doi: 10.1016/0022-1759(86)90536-3. [DOI] [PubMed] [Google Scholar]
  29. van der Westhuyzen D. R., von Holt C. A new procedure for the isolation and fractionation of histones. FEBS Lett. 1971 May 20;14(5):333–337. doi: 10.1016/0014-5793(71)80294-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES